SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Read more breaking news

 

 
News in brief

Ashland expands HPC production at VA plant

By Dan Stanton+

11-Aug-2014
Last updated on 11-Aug-2014 at 15:45 GMT

Ashland's Hopewell, Virginia plant
Ashland's Hopewell, Virginia plant

Fine chemicals manufacturer Ashland has laid down plans to expand a Klucel hydroxypropylcellulose (HPC) plant in Virginia to meet growing pharma demand.

Expansion at the facility in Hopewell, Virginia, is expected to be completed in the second half of 2016 and will add extra capacity for the company’s Klucel HPC product range.

Klucel HPC is used by the pharma industry as a tablet binder and coating ingredient and according to the firm, demand for the ingredient has led to this investment, though no further details were disclosed when this publication contacted Ashland.

However, in a statement Ashland’s VP of Pharmaceutical Specialties said the firm “is committed to the overall pharmaceutical market,” as demonstrated in a number of recent investments in its pharma ingredient network.

Ashland opened a pharmaceutical centre of excellence in Hyderabad, India, earlier this year and recently expanded plants in Wilmington, Delaware, and Texas City, Texas. 

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions